Ascendis Pharma A/S
F:A71
Ascendis Pharma A/S
F:A71
Price:
206
EUR
0.98%
Market Closed
Market Cap:
€11.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Ascendis Pharma A/S
F:A71
|
DK |
|
A
|
Adaro Energy Indonesia TBK PT
SWB:A64
|
ID |
|
N
|
Nucor Corp
XMUN:NUO
|
US |
|
H
|
HCA Healthcare Inc
XMUN:2BH
|
US |
|
ActiveOps PLC
F:95D
|
UK |
|
O
|
Odfjell Drilling Ltd
XBER:OD3
|
BM |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
|
Byline Bancorp Inc
F:44F
|
US |
|
U
|
Ultragenyx Pharmaceutical Inc
F:UP0
|
US |
|
M
|
Mckesson Corp
XMUN:MCK
|
US |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
Ascendis Pharma A/S
Wall Street analysts forecast A71 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for A71 is 243.44 EUR with a low forecast of 209.31 EUR and a high forecast of 291.85 EUR.
Lowest Forecast
Price Target
209.31
EUR
2% Upside
Average Forecast
Price Target
243.44
EUR
18% Upside
Highest Forecast
Price Target
291.85
EUR
42% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
243.44
EUR
243.44
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 243.44 EUR with a low forecast of 209.31 EUR and a high forecast of 291.85 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
23%
23%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 23%.
